Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings

Key TakeawaysZacks earnings estimates for AstraZeneca are currently at $4.06 per share. However, the earnings picture appears to brighten in 2025.The healthcare company has beaten earnings estimates in three of the past four quarters.Register now to see our 7 Best Stocks for the Next 30 Days report - free today!AstraZeneca (AZN) will report its third-quarter earnings on Nov. 12, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $13.04 billion and $1.01 per share, respectiv ...